On March 25, 2022, Carl Sandler provided notice of his resignation as a member of the Board of Directors of Enochian Biosciences Inc. to focus on his other business ventures, with such resignation being effective March 25, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.49 USD | +1.36% | +4.93% | -53.00% |
May. 24 | Renovaro, Amsterdam UMC Cancer Center Plan to Form Joint Venture for Cancer Immunotherapy | MT |
May. 24 | Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy | CI |
1st Jan change | Capi. | |
---|---|---|
-53.00% | 220M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- RENB Stock
- News Renovaro Inc.
- Enochian Biosciences, Inc. Announces Resignation of Carl Sandler as Member of the Board of Directors